{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:01:17Z","timestamp":1761415277637,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.hlc.2009.02.007","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T06:18:00Z","timestamp":1247033880000},"page":"343-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["At Sea with SEAS: The First Clinical Endpoint Trial for Ezetimibe, Treatment of Patients with Mild to Moderate Aortic Stenosis, Ends with Mixed Results and More Controversy"],"prefix":"10.1016","volume":"18","author":[{"given":"Ian","family":"Hamilton-Craig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Kostner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Colquhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan","family":"Woodhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2009.02.007_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjcard.2006.10.064","article-title":"Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study","volume":"99","author":"Rossebo","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2009.02.007_bib2","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.hlc.2009.02.007_bib3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med."},{"issue":"9493","key":"10.1016\/j.hlc.2009.02.007_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.hlc.2009.02.007_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.acra.2004.12.022","article-title":"Association between progression of aortic valve calcification and coronary calcification: assessment by electron beam tomography","volume":"12","author":"Takasu","year":"2005","journal-title":"Acad Radiol"},{"issue":"10","key":"10.1016\/j.hlc.2009.02.007_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/hq1001.098463","article-title":"Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study","volume":"1","author":"Zhao","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"October (10)","key":"10.1016\/j.hlc.2009.02.007_bib7","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1194\/jlr.R500010-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy. Part III. Mechanistically defining the role of hyperlipidemia","volume":"46","author":"Steinberg","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.hlc.2009.02.007_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5694\/j.1326-5377.2008.tb02045.x","article-title":"After ENHANCE, the lipid hypothesis is alive and well","volume":"189","author":"Hamilton-Craig","year":"2008","journal-title":"Med J Aust"},{"issue":"January (1)","key":"10.1016\/j.hlc.2009.02.007_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2007.06.063","article-title":"Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis","volume":"51","author":"Afilalo","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.hlc.2009.02.007_bib10","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMsa0806603","article-title":"Analyses of cancer data from three ezetimibe trials","volume":"359","author":"Peto","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2009.02.007_bib11","doi-asserted-by":"crossref","unstructured":"Stein EA. After ENHANCE\u2013is more LDL cholesterol lowering still better? Clin Chem 2008, April 10; published as doi:10.1373\/clinchem.2008.104893 (accessed August 2, 2008).","DOI":"10.1373\/clinchem.2008.104893"},{"key":"10.1016\/j.hlc.2009.02.007_bib12","unstructured":"IMPROVE-IT Trial. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00202878?term=IMPROVE-IT&rank=1 (accessed August 2, 2008)."},{"issue":"13","key":"10.1016\/j.hlc.2009.02.007_bib13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMsa0806603","article-title":"Analyses of cancer data for three ezetimibe trials","volume":"359","author":"Peto","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.hlc.2009.02.007_bib14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","article-title":"Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis","volume":"110","author":"Rosenhek","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hlc.2009.02.007_bib15","first-page":"378","article-title":"Effect of statin treatment on aortic valve and coronary artery calcification","volume":"16","author":"Mohler","year":"2007","journal-title":"J Heart Valve Dis"},{"issue":"23","key":"10.1016\/j.hlc.2009.02.007_bib16","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2009.02.007_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis","volume":"49","author":"Moura","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hlc.2009.02.007_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1586\/14779072.6.3.385","article-title":"Aortic sclerosis, aortic stenosis and lipid-lowering therapy","volume":"6","author":"Rosenhek","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"10.1016\/j.hlc.2009.02.007_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ahj.2007.03.011","article-title":"Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering in the progression of aortic stenosis: the Aortic Stenosis Progression Observation: measuring Effects of Rosuvastatin (ASTRONOMER) trial","volume":"153","author":"Chan","year":"2007","journal-title":"Am Heart J"},{"issue":"Suppl. E","key":"10.1016\/j.hlc.2009.02.007_bib20","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1093\/eurheartj\/sun014","article-title":"Overview of clinical trials on calcific aortic stenosis","volume":"10","author":"Pedersen","year":"2008","journal-title":"Eur Heart J Suppl"},{"issue":"6-7","key":"10.1016\/j.hlc.2009.02.007_bib21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.biocel.2007.12.006","article-title":"The regulation of matrix metalloproteinases and their inhibitors","volume":"40","author":"Clark","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.hlc.2009.02.007_bib22","unstructured":"Drazen, JM, D\u2019Agostino RB, Ware JH, Morrissey S, Curfman GD. Ezetimibe and cancer\u2014an uncertain association. N Engl J Med 2008; published online at www.nejm.org (article 10.1056\/NEJMe0807200) accessed November 24, 2008."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950609001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950609001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:56:58Z","timestamp":1761415018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950609001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1443950609001292"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2009.02.007","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"At Sea with SEAS: The First Clinical Endpoint Trial for Ezetimibe, Treatment of Patients with Mild to Moderate Aortic Stenosis, Ends with Mixed Results and More Controversy","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2009.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}